| # | Drug | Count |
|---|---|---|
| 0 | PANTOPRAZOLE | 19 |
| 1 | METFORMIN | 15 |
| 2 | METFORMIN ER 500 MG | 12 |
| 3 | METFORMIN ER 750 MG | 12 |
| 4 | PEMBROLIZUMAB | 11 |
| 5 | SITAGLIPTIN | 10 |
| 6 | OMEPRAZOLE MAGNESIUM | 9 |
| 7 | ALLOPURINOL | 8 |
| 8 | ASPIRIN | 8 |
| 9 | LEVOTHYROXINE SODIUM | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HYDROQUINONE | 1 | 0.0017 |
| 1 | DORAVIRINE | 1 | 0.0013 |
| 2 | VANDETANIB | 2 | 0.0011 |
| 3 | BRIGATINIB | 4 | 0.0011 |
| 4 | OXACILLIN SODIUM | 1 | 0.0009 |
| 5 | METRELEPTIN | 1 | 0.0008 |
| 6 | SENNA LAXATIVE | 1 | 0.0008 |
| 7 | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | 1 | 0.0008 |
| 8 | PSYLLIUM HUSK | 1 | 0.0007 |
| 9 | ELUXADOLINE | 2 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 27 |
| 1 | GLP-1 Receptor Agonist [EPC] | 16 |
| 2 | Benzodiazepine [EPC] | 14 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 14 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 13 |
| 5 | Platinum-based Drug [EPC] | 13 |
| 6 | Kinase Inhibitor [EPC] | 11 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 10 |
| 8 | Alkylating Drug [EPC] | 9 |
| 9 | Platelet Aggregation Inhibitor [EPC] | 9 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Melanin Synthesis Inhibitor [EPC] | 1 | 0.0009 |
| 1 | Leptin Analog [EPC] | 1 | 0.0008 |
| 2 | mu-Opioid Receptor Agonist [EPC] | 2 | 0.0007 |
| 3 | CD30-directed Immunoconjugate [EPC] | 3 | 0.0003 |
| 4 | Dopamine-2 Receptor Antagonist [EPC] | 2 | 0.0003 |
| 5 | Tetracycline-class Antibacterial [EPC] | 2 | 0.0003 |
| 6 | Selective T Cell Costimulation Blocker [EPC] | 1 | 0.0002 |
| 7 | GLP-2 Analog [EPC] | 2 | 0.0001 |
| 8 | RNA Synthetase Inhibitor Antibacterial [EPC] | 2 | 0.0001 |
| 9 | Echinocandin Antifungal [EPC] | 1 | 0.0001 |